Alternatives to BioLamina
BioLamina is a Biotechnology tool: developing and manufacturing laminin-based cell culture substrates for advanced cell therapies and drug discovery. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to BioLamina
- Website
Abcam61BiotechnologyCambridge, United Kingdom$256.9MGlobal supplier of life science research tools, including antibodies, reagents, and assays.
- Website
BioLife Solutions54BiotechBothell, United States$96.4MDevelops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.
- Website
Meridian Bioscience55Diagnostic TestingCincinnati, United States$2.5MIntegrated life science company specializing in diagnostic testing solutions and life science raw materials.
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website
Pixelgen Technologies62BiotechnologyStockholm, Sweden$43.5MA life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
- Website
Quartzy60BiotechnologyHayward, USA$40.0MA vertically-integrated procurement platform for the life sciences industry.
- Website
Celerion59BiotechnologyLincoln, USA$45.0MA global leader in clinical pharmacology and bioanalytical sciences.
- Website
KaliVir Immunotherapeutics, Inc.57BiotechnologyPittsburgh, United States$14.0MClinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.
- Website
Adaptyv Biosystems57BiotechnologyLausanne, Switzerland$40.0MAutomated wet lab for AI-driven protein design, enabling rapid synthesis, expression, and testing of thousands of protein designs.
- Website
Cellares54BiotechnologySouth San Francisco, USA$327.0MThe first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.
- Website
Semarion53BiotechnologyCambridge, United Kingdom$8.7MA University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology.
- Website
Ray Therapeutics53BiotechnologyBerkeley, USA$243.0MPioneering vision restoration therapies for severe retinal degenerations.
- Website
Rejuvenate Bio52BiotechnologyCambridge, USA$6.0MDeveloping novel therapies to reverse aging and extend lifespan.
- Website
Immix Biopharma, Inc.51BiotechnologyLos Angeles, United States$5.0MA clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.
- Website LILife Biosciences49BiotechnologyBoston, USA$100.0M
Developing epigenetic reprogramming drugs for age restoration.
- Website
EnteroBiotix48BiotechnologyGlasgow, United Kingdom$40.5MDeveloping microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health.
- Website
Tozaro47BiotechnologyLondon, United Kingdom$6.9MPlatform designed to cut cell and gene therapy production costs.
- Website SCScinus Group47BiotechnologyUtrecht, Netherlands$3.0M
Develops and distributes bioreactor technology for stem cell cultivation.
- Website TOTolemy Bio46BiotechnologyCambridge, United Kingdom$1.4M
AI-enabled technology for cell biology research and biopharma development.
- Website
Generate Biomedicines71BiotechnologySomerville, United StatesAI-driven biotechnology company developing novel protein therapeutics through generative biology.
Showing the 20 closest matches. See the rest on the BioLamina profile.